European Medicines Agency (EMA) to Amsterdam

The European Medicines Agency is relocating from London to Amsterdam. Various Dutch government authorities are working together to make sure the move goes smoothly.

What is the European Medicines Agency (EMA)?

The European Medicines Agency (EMA) was set up in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.


EMA is leaving London because of the UK’s decision to leave the European Union (Brexit). On 20 November 2017 the Council of the European Union announced that EMA would relocate to Amsterdam in 2019.

Temporary and permanent premises for EMA

The European Medicines Agency (EMA) will move from London to Amsterdam before 30 March 2019. Until the completion of its new headquarters in the Zuidas business district in November 2019, the EMA will occupy temporary premises in the Spark Building, close to Amsterdam Sloterdijk station.

Read more about relocation of employees, finding education for their children and the time line

Government partnership

To ensure that the relocation goes as smoothly as possible, these government authorities are working in partnership:

  • the Ministry of Health, Welfare and Sport
  • the Ministry of Foreign Affairs
  • the Ministry of Education, Culture and Science
  • the Central Government Real Estate Agency
  • the Municipality of Amsterdam
  • the Zuidas business district of Amsterdam.

Facts and figures about EMA

  • EMA had a budget of €324 million in 2016. About half of this was spent directly in the host country.
  • EMA approves about 90 new medicines every year.
  • Around 1.2 million adverse reactions to medicines are recorded in its database.
  • EMA’s network includes 40 pharmaceutical authorities and almost 4,000 experts.
  • EMA receives 65,000 visitors and holds 565 international meetings per year.
  • EMA employs almost 900 staff at its current headquarters in Canary Wharf, London.


See also